Applied Microarrays

The companies will jointly offer services and equipment solutions for the development, high-volume manufacture, and launch of multiplexed in vitro diagnostics.

Applied Microarrays and InDevR this week announced a new partnership that will pair AMI's contract array manufacturing resources with InDevR's instrumentation and assay development capabilities.

NEW YORK (GenomeWeb) – InDevR and Applied Microarrays said today that they will work together to offer custom microarrays, instruments, and reagents for multiplexed assays.

Schott, a Jena, Germany-based provider of array surfaces, kits, and reagents, has tapped Applied Microarrays to serve as its distributor in North America.

NEW YORK (GenomeWeb News) – Applied Microarrays earlier this week began distributing Schott Nexterion products in the US and Canada under an agreement forged by the two firms.

This article has been updated from a previous version to include additional comments from AMI.

The bulk of AMI's sales have been derived from printing protein arrays and plates for customers involved in biomarker discovery.

According to the firm's CEO, the majority of the company's sales come from contract manufacturing, while sales of legacy CodeLink bioarray products now account for less than a tenth of AMI's total revenues.

Affy transferred ownership of the 10,000-square-foot Clinical Services Lab to Navigenics earlier this year though an increasing number of drug makers outsource their molecular diagnostic research needs to CLIA labs.

Both companies separately last week announced plans to expand the scope of their respective businesses in response to what they said is increased desire from customers to outsource their array production and array-based research projects.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.